Published in Oncologist on February 01, 2005
A clinical overview of pheochromocytomas/paragangliomas and carcinoid tumors. Nucl Med Biol (2008) 1.39
99mTc-EDDA/HYNIC-octreotate scintigraphy, an efficient method for the detection and staging of carcinoid tumours: results of 3 years' experience. Eur J Nucl Med Mol Imaging (2006) 1.13
Unusual orange-colored choroidal metastases. J Ophthalmic Vis Res (2013) 0.98
Surgical treatment of a rare primary renal carcinoid tumor with liver metastasis. World J Surg Oncol (2008) 0.96
Differential cytotoxicity of novel somatostatin and dopamine chimeric compounds on bronchopulmonary and small intestinal neuroendocrine tumor cell lines. Cancer (2008) 0.93
Primary neuroendocrine tumor of the sacrum: case report and review of the literature. Skeletal Radiol (2009) 0.92
Neuroendocrine tumors of the gallbladder: a case report and review of the literature. J Med Case Rep (2011) 0.89
Consensus recommendations for the diagnosis and management of well-differentiated gastroenterohepatic neuroendocrine tumours: a revised statement from a Canadian National Expert Group. Curr Oncol (2010) 0.89
Detection of hepatic metastases from carcinoid tumor: prospective evaluation of contrast-enhanced ultrasonography. Dig Dis Sci (2008) 0.89
Primary neuroendocrine tumor (carcinoid tumor) of the testis: a case report with review of literature. Am J Case Rep (2015) 0.88
Typical bronchial carcinoid metastasizing to the brain: a case presentation. Case Rep Oncol (2011) 0.88
Bronchial carcinoid in a 39-year-old man treated for bronchial asthma: a case report. Cases J (2008) 0.86
Uncommon testicular metastasis of a primary neuroendocrine tumour of the lung. Can Urol Assoc J (2013) 0.84
Skeletal metastasis of carcinoid tumors: Two case reports and review of the literature. Oncol Lett (2012) 0.83
Imaging myocardial carcinoid with T2-STIR CMR. J Cardiovasc Magn Reson (2008) 0.82
Clinical characteristics and prognosis of primary pancreatic carcinoid tumors: A report of 13 cases from a single institution. Oncol Lett (2014) 0.82
Chrysin suppresses achaete-scute complex-like 1 and alters the neuroendocrine phenotype of carcinoids. Cancer Gene Ther (2015) 0.80
Molecular evidence for the bi-clonal origin of neuroendocrine tumor derived metastases. BMC Genomics (2012) 0.79
Atypical presentation of carcinoid tumor with unresolved right shoulder pain: a case report. J Med Case Rep (2014) 0.79
Combination of carbonic anhydrase inhibitor, acetazolamide, and sulforaphane, reduces the viability and growth of bronchial carcinoid cell lines. BMC Cancer (2013) 0.78
Excessive muscle paralysis due to pulmonary carcinoid -a case report. Clin Med Insights Case Rep (2012) 0.78
Primary lung carcinoid, a rare cause of paraparesis: report of a case and review of the literature. J Thorac Dis (2012) 0.77
Unusual Malignant Solid Neoplasms of the Kidney: Cross-Sectional Imaging Findings. Korean J Radiol (2015) 0.77
Primary cervical spine carcinoid tumor in a woman with arm paresthesias and weakness: a case report. J Med Case Rep (2013) 0.76
Brain metastasis from neuroendocrine tumor of the gallbladder: a rare entity. South Asian J Cancer (2013) 0.76
An Asymptomatic Primary Renal Carcinoid Tumor: A Case Report. Urol Case Rep (2016) 0.75
A full house of metastatic carcinoid disease. BMJ Case Rep (2012) 0.75
A cause to consider for chronic unresolving diarrhea. Gastroenterol Rep (Oxf) (2014) 0.75
The PARP inhibitor ABT-888 potentiates dacarbazine-induced cell death in carcinoids. Cancer Gene Ther (2016) 0.75
Primary testicular carcinoid tumour with mature teratoma in undescended testis metastatic to lymph nodes. Can Urol Assoc J (2014) 0.75
Sustained response to FOLFOX and Bevacizumab in metastatic bronchial carcinoid - A case report and review of the literature. J Gastrointest Oncol (2011) 0.75
Pregnant with metastatic neuroendocrine tumour of the ovary: what now? Ecancermedicalscience (2012) 0.75
Small bowel carcinoid: a rare cause of bowel obstruction. BMJ Case Rep (2013) 0.75
Carcinoid tumor with localized bronchiectasis. Tanaffos (2013) 0.75
A Unique Case of Diffuse Metastatic Neuroendocrine Cancer with Subcutaneous Nodules on (18)F-Fluorodeoxyglucose Positron Emission Tomography/Computer Assisted Tomography. World J Nucl Med (2015) 0.75
Malignant metastatic carcinoid presenting as brain tumor. Asian J Neurosurg (2016) 0.75
Surgical management and outcome of rectal carcinoids in a university hospital. World J Surg Oncol (2015) 0.75
A case of uncontrolled asthma. Allergy Rhinol (Providence) (2011) 0.75
Genome-wide gene expression analysis of chemoresistant pulmonary carcinoid cells. Lung Cancer (Auckl) (2010) 0.75
Identification of a terminal ileum carcinoid tumour during bowel screening colonoscopy - should terminal ileoscopy be performed as best practice? J Surg Case Rep (2012) 0.75
Paraneoplastic Cushing's syndrome associated with bronchopulmonary carcinoid tumor in youth: A case report and review of the literature. Oncol Lett (2016) 0.75
Nothing But NET: A Review of Neuroendocrine Tumors and Carcinomas. Neoplasia (2017) 0.75
Neuroendocrine Testicular Tumors: A Systematic Review and Meta-Analysis. Curr Urol (2017) 0.75
Molecular response assessed by (68)Ga-DOTANOC and survival after (90)Y microsphere therapy in patients with liver metastases from neuroendocrine tumours. Eur J Nucl Med Mol Imaging (2015) 0.75
ENETS Consensus Guidelines for the management of patients with digestive neuroendocrine neoplasms of the digestive system: well-differentiated pancreatic non-functioning tumors. Neuroendocrinology (2012) 2.12
T(11;18) is a marker for all stage gastric MALT lymphomas that will not respond to H. pylori eradication. Gastroenterology (2002) 2.06
Surveillance for hereditary nonpolyposis colorectal cancer: a long-term study on 114 families. Dis Colon Rectum (2002) 1.91
Classification of low-grade neuroendocrine tumors of midgut and unknown origin. Hum Pathol (2002) 1.47
Screening behavior of individuals at high risk for colorectal cancer. Gastroenterology (2005) 1.39
Dynamic Bayesian networks as prognostic models for clinical patient management. J Biomed Inform (2008) 1.16
Incidence and survival of neuroendocrine tumours in the Netherlands according to histological grade: experience of two decades of cancer registry. Eur J Cancer (2013) 1.05
Chromogranin-A and N-terminal pro-brain natriuretic peptide: an excellent pair of biomarkers for diagnostics in patients with neuroendocrine tumor. J Clin Oncol (2009) 1.00
Chromogranin A as an alternative to 5-hydroxyindoleacetic acid in the evaluation of symptoms during treatment of patients with neuroendocrine Tumors. Neuroendocrinology (2008) 0.98
Choice of tumour markers in patients with neuroendocrine tumours is dependent on the histological grade. A marker study of Chromogranin A, Neuron specific enolase, Progastrin-releasing peptide and cytokeratin fragments. Eur J Cancer (2011) 0.96
The role of parallel stent insertion in patients with esophagorespiratory fistulas. Gastrointest Endosc (2002) 0.95
Detection of small-bowel neuroendocrine tumors by video capsule endoscopy. Gastrointest Endosc (2006) 0.94
Colorectal cancer in the family: psychosocial distress and social issues in the years following genetic counselling. Hered Cancer Clin Pract (2007) 0.93
Daily cyclic changes in the urinary excretion of 5-hydroxyindoleacetic acid in patients with carcinoid tumors. Clin Chem (2004) 0.89
Predicting carcinoid heart disease with the noisy-threshold classifier. Artif Intell Med (2006) 0.83
Well-differentiated duodenal tumor/carcinoma (excluding gastrinomas). Neuroendocrinology (2007) 0.83
Local treatment in unresectable hepatic metastases of carcinoid tumors: Experiences with hepatic artery embolization and radiofrequency ablation. World J Surg Oncol (2005) 0.80
Increase of angiogenic growth factors after hepatic artery embolization in patients with neuroendocrine tumours. Tumour Biol (2011) 0.80
Somatostatin receptor scintigraphy and chromogranin A assay in staging and follow-up of patients with well-differentiated neuroendocrine tumors. Nucl Med Commun (2011) 0.78
Selecting treatment strategies with dynamic limited-memory influence diagrams. Artif Intell Med (2007) 0.77
[131I]MIBG radionuclide therapy in carcinoid syndrome. Eur J Surg Oncol (2002) 0.75
Carcinoid heart disease. N Engl J Med (2003) 0.75
On the use of vignettes for eliciting test-selection strategies. Stud Health Technol Inform (2003) 0.75